| LEO Pharma London School of Economics and Political Science McKinsey & Company Med-Fine Capital Merck KGaA Novo Holdings Nxera Pharma OliX Pharmaceuticals Panacea Capital Parexel Pivotal bioVenture Partners RA Capital Ryvu Therapeutics Sofinnova Partners Swedish Orphan Biovitrum (SOBI) TPG Life Sciences Innovations True Light Capital Unicycive Therapeutics WuXi Biologics WuXi XDC Yale Ventures And many more...
|